Indigenous Fire Management, Oliver Sacks Film. September 25, 2020, Part 1
Science Friday
Science Friday and WNYC Studios
4.4 • 6.3K Ratings
🗓️ 25 September 2020
⏱️ 47 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This is Science Friday. I'm Iroflato. A bit later in the hour, we'll talk about indigenous methods of wildfire management, |
| 0:07.6 | and we'll talk with director Rick Burns about his new biography of Oliver Sacks. But first, the race for the COVID-19 vaccine is heating up. |
| 0:17.9 | Just this week, Johnson and Johnson announced its vaccine is entering a final stage of |
| 0:23.6 | clinical trials, making it the fourth U.S. company to do so. So what does this mean for when an actual |
| 0:30.9 | vaccine makes it to a major muscle of mine? Here with me to talk about this and other news from the |
| 0:37.2 | week is Sarah Zang, |
| 0:38.8 | staff writer at the Atlantic in Washington, D.C. Welcome back to Science Friday. Hi, |
| 0:44.6 | Ira. Good to talk to you. Nice to have you. Okay, let's start with what's going on with a COVID-19 vaccine. |
| 0:51.5 | What does it mean that four vaccines are in phase three trials? Yeah, so phase three |
| 0:57.6 | trials are the last step before final approval. And so these are really large trials that have |
| 1:03.4 | tens of thousands of people. From the protocols that have been released, these trials will |
| 1:07.6 | probably take a few months themselves. So it'll probably take a few more months before we really know any of these vaccines are effective and safe. But after that, |
| 1:15.7 | state and local health departments are kind of preparing for what they've called the largest, |
| 1:19.8 | most complex vaccination program they've ever had to do in their history. And that has to do, |
| 1:25.9 | one, with just the sheer scale of trying to vaccinate |
| 1:28.2 | hundreds of millions of Americans. And second has to do with the kind of the particular |
| 1:33.0 | characteristics of some of the leading vaccine candidates, especially the two that are furthest |
| 1:37.7 | along in clinical trials. So they use a new technology that is just both new and also the vaccines |
| 1:43.8 | themselves are extremely physically fragile, |
| 1:46.0 | which means that they just have to be kept at really low freezer temperatures, as low as negative |
| 1:50.3 | 94 degrees Fahrenheit. Isn't that going to be a problem if you have to keep a vaccine at |
| 1:55.0 | negative 94 Fahrenheit? How do you move it around? Yeah, exactly. This is what people are trying to figure |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Science Friday and WNYC Studios, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Science Friday and WNYC Studios and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

